Inside informationEnglish
Ipsen expands early development pipeline with Simcere Zaiming’s innovative antibody drug conjugate
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Ipsen SA
- Filed
- 22/12/2025, 07:00
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 116094_20251222